Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Jon R. Wiener"'
Autor:
Gary E. Gallick, T. Christopher Windham, Michael T. Deavers, Peter F. Thall, Robert C. Bast, Veronica C. Estrella, Jon R. Wiener, Gordon B. Mills, Nila U. Parikh
Publikováno v:
Gynecologic Oncology. 88:73-79
Objective. The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers. Methods. Western analysis and immune complex kinase assays were performed on a panel of human ovari
Autor:
Mark A. Pershouse, Yinhua Yu, Ann M. Killary, Fengji Xu, Bruce D. Cuevas, Gordon B. Mills, Yofre Cabeza-Arvelaiz, Robert C. Bast, Jon R. Wiener, M. Mercedes Lovell, Russell P. Kruzelock
Publikováno v:
Oncogene. 19:6277-6285
The identity of many tumor suppressor genes important in epithelial ovarian cancer tumorigenesis remains unknown. In an effort to localize a novel tumor suppressor on chromosome 22, a psv2neo tagged human chromosome 22 was transferred into the malign
Autor:
Robert C. Bast, Fengji Xu, Cinda M. Boyer, K. DeSombre, Kathy O'Briant, Jon R. Wiener, Blanche Simpson Bast, Lajos Pusztai, Marilee Greenwald, G. Scott Dean
Publikováno v:
International Journal of Cancer. 82:525-531
Different epitopes on the extracellular domain of the HER-2 receptor can serve as distinct targets for immunotoxins. To determine the optimal epitope target for immunotoxin therapy, 7 anti-HER-2 ricin A chain murine monoclonal immunotoxins, each reac
Autor:
B. J. Kerns, Robert C. Bast, Jon R. Wiener, Neville F. Hacker, Caroline Van Haaften-Day, Cinda M. Boyer, Debra N. Jensen, Peter Russell
Publikováno v:
Cancer. 77:2092-2098
BACKGROUND Tumors of borderline malignancy are still a controversial subgroup of ovarian neoplasms. The expression of several cell regulatory proteins was studied to characterize the molecular phenotype of these tumors, and to compare them with their
Publikováno v:
Gynecologic Oncology. 53:59-63
Recombinant interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) can induce endogenous TNF-alpha mRNA expression and stimulate proliferation of epithelial ovarian cancer cells. In a previous report, proliferation induced by either cytokin
Autor:
Mark R. Conaway, Entrane L. Harvey, B. J. Kerns, Robert C. Bast, J. Dirk lglehart, Andrew Berchuck, Jon R. Wiener
Publikováno v:
JNCI Journal of the National Cancer Institute. 86:372-378
BACKGROUND The p185c-erbB-2 growth factor receptor protein tyrosine kinase (PTK) is overexpressed in one third of human breast cancer patients and indicates a poor prognosis in these patients. Protein tyrosine phosphatases (PTPs) may balance PTK acti
Autor:
Gary E. Gallick, Jon R. Wiener
Publikováno v:
Signaling Pathways in Cancer Pathogenesis and Therapy ISBN: 9781461412151
From studies on tumor development in animals to identification of the first oncogene, the Src family of nonreceptor tyrosine kinases has been a focus of intense biological and medical interest for over 100 years. Aberrant signaling through Src and it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::523e7c6e882dac3d9ee467aeb0208e11
https://doi.org/10.1007/978-1-4614-1216-8_4
https://doi.org/10.1007/978-1-4614-1216-8_4
Autor:
Feng Ji Xu, Jon R. Wiener, Robert C. Bast, Ian Jacobs, Cinda M. Boyer, Shu Wu, Andrew Berchuck, Matt Kohler
Publikováno v:
Cancer. 71:1597-1601
BACKGROUND: As in the case of other epithelial neoplasms, most ovarian cancers arise from single clones of cells that have undergone multiple genetic alterations. A comparison of normal and malignant ovarian epithelium has identified several differen
Publikováno v:
Current Opinion in Oncology. 4:946-954
Growth of epithelial ovarian cancer is influenced by several factors including transforming growth factor-alpha and transforming growth factor-beta, macrophage colony stimulating factor, tumor necrosis factor-alpha, interleukin-1 and interleukin-6, c
Autor:
Terri B. Pustilnik, Fazal H. Tabassam, Astrid Eder, Jon R. Wiener, Gordon B. Mills, Shuying Liu, Gary E. Gallick, Veronica C. Estrella, Francois Xavier Claret
Publikováno v:
International Journal of Oncology.
Lysophosphatidic acid (LPA) is an important intercellular signaling molecule involved in a myriad of biological responses. Elevated concentrations of LPA are present in the ascites and plasma of ovarian cancer patients suggesting a role for LPA in th